Centre of Excellence for Decentralised Clinical Trials

Trials@Home aims to reshape clinical trial design, conduct and operations, by developing and piloting standards, recommendations and tools for the definition and operationalisation of decentralised clinical trials (DCTs) in Europe.

Centre of Excellence Remote and Decentralised Clinical Trials

Trials@Home aims to reshape clinical trial design, conduct and operations, by developing and piloting standards, recommendations and tools for the definition and operationalisation of remote decentralised clinical trials (RDCTs) in Europe.

*

Key objectives:

  • Defining the best practices for the conduct of DCTs.
  • Identifying technologies and other operational innovative approaches for DCTs and selecting the appropriate technology package to be used for RADIAL, the pan-EU pilot.
  • Designing and running a pan-EU pilot, comparing the scientific and operational quality of the DCT with traditional trial approaches and evaluating the feasibility of the DCT.
  • Identifying, mapping and analysing the relevant ethical, quality, regulatory, legal and organisational barriers and enablers of DCTs.
  • Consulting with stakeholders and promoting the outcomes from the Trials@Home consortium through targeted communication, dissemination and training activities.
  • Providing recommendations with supporting tools for implementing DCTs in Europe and contributing to the update of ICH guidelines on DCTs.
More
*

About us

*

About DCT’s

*

About the ESP & PEP

News, Events & Publications

*

Trials@Home – Annual Meeting 2022 – Report

Wuppertal

The 2022 Trials@Home Annual Meeting took place in Bayer’s facilities in Wuppertal, where we had two full days of meetings, presentations, and networking. The project thanks Bayer for allowing use of their space for this meeting and for their support in the meeting organisation. The project also thanks the members from the Scientific Advisory Board (SAB), External Stakeholder Platform (ESP) and Patient Expert Panel (PEP) for their invaluable contributions so far.

With about 60 people in the room and 40 online attendees, we had a great time with a lot of inspiring and thought-provoking sessions. Some highlights are presented below.

RADIAL is approved in Denmark!

Utrecht, November 2, 2022

On the 5th of September the team submitted all the necessary documents related to RADIAL for the second part of the CTIS submission and … on the 2nd of November we achieved yet another milestone as the Danish authorities have approved our study. The final preparations are now in full swing to get the last details and approvals ready and we hope to recruit our first patients before the end of the year.

We’re very excited about his and hope to share the approvals for the other countries soon.

Upcoming Events & Speaking Engagements 

Click here to see where you can hear the latest about the project and our RADIAL study.

Click here to see our latest publications

Follow us on LinkedIn
Follow us on Twitter
Sign up for our Newsletter